Next-generation muscle-directed gene therapy by in silico vector design
Adeno-associated viral vectors (AAV) are being developed for gene therapy of skeletal muscle, but it is a challenge to achieve robust gene expression. Here, the authors identify muscle-specific cisregulatory elements that lead to a substantial increase in micro-dystrophin and follistatin expression,...
Guardado en:
Autores principales: | S. Sarcar, W. Tulalamba, M. Y. Rincon, J. Tipanee, H. Q. Pham, H. Evens, D. Boon, E. Samara-Kuko, M. Keyaerts, M. Loperfido, E. Berardi, S. Jarmin, P. In’t Veld, G. Dickson, T. Lahoutte, M. Sampaolesi, P. De Bleser, T. VandenDriessche, M. K. Chuah |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c5d6b54327424a9fb828402310c7a87f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants
por: Jonas Weinmann, et al.
Publicado: (2020) -
Atonal homolog 1 is a tumor suppressor gene.
por: Wouter Bossuyt, et al.
Publicado: (2009) -
In silico pharmacology
Publicado: (2013) -
In silico biology
Publicado: (1998) -
In Silico Prediction of Steroids and Triterpenoids as Potential Regulators of Lipid Metabolism
por: Valery M. Dembitsky
Publicado: (2021)